Header Logo

Connection

LILY CHENG to Human papillomavirus 16

Back to Details
This is a "connection" page, showing publications LILY CHENG has written about Human papillomavirus 16.
LILY CHENG
Connection Strength
0.052
Human papillomavirus 16
  1. Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2023 02 01; 29(3):560-570.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.